Inventor · disambiguated record
Kalyani Mondal
Also filed as: MONDAL KALYANI
9 granted patents·22 citations·filing 2015–2023
84Inventor score
Files withNGM BIOPHARMACEUTICALS INC9
Top patents by PatentIndex Score
9 records- 0195US9738716B2Beta klotho binding proteins and methods of use thereofNGM BIOPHARMACEUTICALS INC·Filed 2015·Granted Aug 22, 2017·9 cites·6 claims
- 0293US10093735B2Beta-klotho binding proteinsNGM BIOPHARMACEUTICALS INC·Filed 2017·Granted Oct 9, 2018·4 cites·15 claims
- 0389US10744191B2Beta klotho-binding proteins and methods of use thereofNGM BIOPHARMACEUTICALS INC·Filed 2018·Granted Aug 18, 2020·3 cites·28 claims
- 0488US10800843B2Beta klotho-binding proteinsNGM BIOPHARMACEUTICALS INC·Filed 2016·Granted Oct 13, 2020·3 cites·14 claims
- 0586US11802155B2ILT-binding agents and methods of use thereofNGM BIOPHARMACEUTICALS INC·Filed 2021·Granted Oct 31, 2023·1 cites·34 claims
- 0686US11596676B2Methods of treating nonalcoholic steatohepatitis comprising administering an anti-human beta klotho antibody or binding fragment thereofNGM BIOPHARMACEUTICALS INC·Filed 2020·Granted Mar 7, 2023·1 cites·21 claims
- 0785US11667708B2Anti-human beta klotho antibody or binding fragment thereof and methods of their useNGM BIOPHARMACEUTICALS INC·Filed 2020·Granted Jun 6, 2023·1 cites·59 claims
- 0884US12378312B2Polynucleotides encoding human beta klotho antibodies or binding fragments thereof and methods of use thereofNGM BIOPHARMACEUTICALS INC·Filed 2023·Granted Aug 5, 2025·0 cites·23 claims
- 0978US12410251B2ILT-binding agents and methods of use thereofNGM BIOPHARMACEUTICALS INC·Filed 2023·Granted Sep 9, 2025·0 cites·27 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →